Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Movantik for Opioid-Related Esophageal Disorders

NCT02998606 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT02998606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02998606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Movantik for Opioid-Related Esophageal Disorders
Lead sponsor
Temple University
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2017
Completion date
October 31, 2018
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophagus disorder, opioid-induced disorders